Literature DB >> 24953910

Relationship of high sensitivity C-reactive protein with cardiac biomarkers in patients presenting with acute coronary syndrome.

Zohair Al Aseri1, Syed Shahid Habib2, Abdullah Saleh Alhomida3, Haseeb Ahmad Khan3.   

Abstract

OBJECTIVE: To determine high sensitivity C-reactive protein (hsCRP) levels in patients with acute myocardial infarction (AMI) and its correlation with classical enzyme markers of myocardial damage. STUDY
DESIGN: Observational study. PLACE AND DURATION OF STUDY: Department of Emergency Medicine at King Khalid University Hospital, King Saud University, Riyadh and Department of Physiology, from August 2010 to December 2011.
METHODOLOGY: Consecutive eligible patients with either ST elevation myocardial infarction (STEMI) or non-ST elevation myocardial infarction (NSTEMI) who were admitted to the Emergency Department of King Khalid University Hospital were recruited. A total of 71 subjects were finally selected for the study. The hsCRP, Troponin I (Trop I), creatine kinase myocardial bound (CK-MB), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) concentrations of all patients with an acute myocardial infarction (AMI) were measured.
RESULTS: Among all patients 34 (47.9%) patients had diabetes mellitus, 21 (29.6%) were hypertensive, and 16 (22.5%) had no associated illness. Patients with STEMI had significantly higher levels of CKMB (p=0.0348), LDH (p=0.0471) and hsCRP (p=0.0231) compared to NSTEMI patients. While the differences were non-significant for Trop I (p=0.7022), AST (p=0.9729) and Lp(a) (p=0.5985). Spearman's correlations revealed that CRP correlated significantly with Trop I, CK-MB and LDH. There was a significant predictive relationship of hsCRP with Trop I, LDH and CK-MB while with AST it was nonsignificant.
CONCLUSION: High sensitivity CRP levels is a significant predictor of standard markers for myocardial damage and it may be a useful prognostic marker in acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24953910     DOI: 06.2014/JCPSP.387391

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  3 in total

Review 1.  Electroanalytical point-of-care detection of gold standard and emerging cardiac biomarkers for stratification and monitoring in intensive care medicine - a review.

Authors:  Robert D Crapnell; Nina C Dempsey; Evelyn Sigley; Ascanio Tridente; Craig E Banks
Journal:  Mikrochim Acta       Date:  2022-03-12       Impact factor: 6.408

2.  Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome.

Authors:  Kwi Hyun Bae; Sung Woo Kim; Yeon Kyung Choi; Jung Beom Seo; Namkyun Kim; Chang Yeon Kim; Won Kee Lee; Sungwoo Lee; Jung Guk Kim; In Kyu Lee; Jang Hoon Lee; Keun Gyu Park
Journal:  Diabetes Metab J       Date:  2018-05-02       Impact factor: 5.376

3.  Changes of cardiac troponin I and hypersensitive C-reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment.

Authors:  Li Wang; Bing Liao; Jian Yu; Ling Chen; Xiaozhong Cai; Li Liu; Kaiwen Hou; Minghao Zhang
Journal:  Exp Ther Med       Date:  2019-12-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.